Opportunity Information: Apply for RFA DA 23 006
The NIH grant opportunity "Implementing Comprehensive HIV services in Syringe Service Program (SSP) Settings" (RFA-DA-23-006) supports implementation-focused research to build, test, and scale practical models for delivering integrated HIV prevention and HIV care within syringe service program environments. The core idea is that SSPs have expanded rapidly across the United States and now operate in a wider variety of settings than in the past, including health departments and Federally Qualified Health Centers (FQHCs), alongside more traditional community-based organizations (CBOs) and AIDS service organizations. Because SSPs often have frequent, ongoing contact with people who inject drugs (PWID) and their social networks (including non-injectors), they are positioned to improve engagement and re-engagement across the full HIV prevention and treatment continua, not just provide one-off services.
A major problem the funding opportunity aims to address is the uneven capacity of SSPs to provide comprehensive HIV-related services. Many newer SSPs, including those in rural areas, may have limited expertise in substance use services beyond syringe access and may have minimal infrastructure for HIV care. Even more established SSPs often stop at HIV testing and depend heavily on referrals for PrEP, antiretroviral treatment, linkage to HIV medical care, retention support, and other services, with limited ability to track follow-through. The opportunity highlights a need for sustainable, integrated approaches that move beyond referrals alone and instead embed effective HIV prevention and care practices within SSP workflows in ways that match the realities of these settings.
The notice also reflects the changing operating environment for SSPs, particularly the disruptions caused by the COVID-19 pandemic, which forced many programs to restructure services and, in some cases, close temporarily or permanently. In parallel, the CDC is building stronger national infrastructure to monitor SSPs, survey clients, and develop technical assistance strategies. NIH is positioning this research program as a complementary effort: it seeks rigorous implementation research evidence on what models work best, for whom, and under what conditions, so that SSPs can more reliably deliver or coordinate comprehensive HIV services. The opportunity also notes alignment with broader federal support for SSP settings, including SAMHSA efforts, reinforcing that the intent is both practical and systems-oriented.
This is an R01 funding mechanism and is explicitly labeled "Clinical Trial Required," meaning applicants are expected to include a clinical trial component in their proposed research. In practice, that signals NIH wants robust testing of implementation strategies or service delivery models that can be evaluated with clinical-trial rigor, rather than purely observational studies or descriptive program reports. The focus is not simply on whether HIV services are beneficial in general, but on how to implement them effectively and sustainably in real-world SSP contexts, including settings with limited resources, limited specialty expertise, and varying local policy and public health environments.
Eligible applicants are broad and include many government entities and organizational types: state, county, city or township governments; special district governments; independent school districts; public housing authorities/Indian housing authorities; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized tribal governments and other tribal organizations; nonprofits with or without 501(c)(3) status; for-profit organizations (other than small businesses) and small businesses; and other entities. The announcement also emphasizes inclusion of a range of mission-driven institutions and organizations such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), along with faith-based and community-based organizations, regional organizations, and U.S. territories or possessions.
Foreign eligibility is limited. Non-domestic (non-U.S.) entities and non-domestic components of U.S. organizations are not eligible to apply. However, foreign components, as defined by NIH policy, are allowed, which typically means a U.S. applicant organization can include certain foreign collaborations or activities when appropriately justified and compliant with NIH rules.
Administratively, the opportunity is listed under the National Institutes of Health as a discretionary grant in the education and health activity category, with CFDA number 93.279. The original closing date shown is 2023-08-11, and the record creation date is 2022-02-25. The announcement text provided does not specify an award ceiling or expected number of awards, indicating those details were either not included in the excerpt or were not set in the source listing.Apply for RFA DA 23 006
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Implementing Comprehensive HIV services in Syringe Service Program (SSP) Settings (R01 - Clinical Trial Required)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279.
- This funding opportunity was created on 2022-02-25.
- Applicants must submit their applications by 2023-08-11. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the name of this NIH funding opportunity?
The opportunity is titled "Implementing Comprehensive HIV services in Syringe Service Program (SSP) Settings" and is identified as RFA-DA-23-006.
What is the main goal of RFA-DA-23-006?
The main goal is to support implementation-focused research that builds, tests, and scales practical models for delivering integrated HIV prevention and HIV care within syringe service program (SSP) environments.
What types of research does this opportunity emphasize?
This opportunity emphasizes rigorous implementation research focused on how to put comprehensive HIV prevention and treatment practices into routine use within SSP workflows, and how to sustain those practices in real-world settings.
Why are SSPs a focus for comprehensive HIV services?
SSPs often have frequent, ongoing contact with people who inject drugs (PWID) and their social networks (including non-injectors). Because of that recurring engagement, SSPs may be well-positioned to improve engagement and re-engagement across the full HIV prevention and treatment continua rather than only providing one-time services.
What problem is the NIH trying to address with this funding opportunity?
The opportunity targets uneven capacity across SSPs to provide comprehensive HIV-related services. Many SSPs, especially newer programs and those in rural areas, may have limited infrastructure for HIV care and limited expertise in substance use services beyond syringe access. Even established SSPs may stop at HIV testing and rely heavily on referrals for additional services, with limited ability to track whether clients successfully connect to care.
What does "moving beyond referrals" mean in the context of this RFA?
It refers to developing and testing sustainable, integrated approaches that embed effective HIV prevention and care practices within SSP operations, rather than relying primarily on external referrals for services like PrEP, antiretroviral treatment, linkage to HIV medical care, and retention support.
What kinds of SSP settings are included in the rationale for this opportunity?
The opportunity notes that SSPs now operate in a wider variety of settings than in the past, including health departments and Federally Qualified Health Centers (FQHCs), as well as more traditional community-based organizations (CBOs) and AIDS service organizations.
How does the COVID-19 pandemic relate to this funding opportunity?
The opportunity highlights that COVID-19 disrupted SSP operations, forcing many programs to restructure services and, in some cases, close temporarily or permanently. This changing operating environment increases the need for practical, sustainable implementation strategies that work under real-world constraints.
How does this NIH effort relate to CDC work on SSPs?
The opportunity describes CDC efforts to strengthen national infrastructure to monitor SSPs, survey clients, and develop technical assistance strategies. NIH positions this RFA as a complementary research effort that produces rigorous implementation research evidence on what models work best, for whom, and under what conditions.
Is this funding intended to support practical, real-world service delivery models?
Yes. The stated intent is practical and systems-oriented: to generate evidence on implementation models that can be embedded into SSP workflows and sustained across a range of SSP contexts, including those with limited resources or specialty expertise.
What is the funding mechanism for this opportunity?
This opportunity uses the NIH R01 research project grant mechanism.
Does this RFA require a clinical trial?
Yes. It is explicitly labeled "Clinical Trial Required," meaning applicants are expected to include a clinical trial component as part of their proposed research.
What does "Clinical Trial Required" signal about the kind of projects NIH is seeking?
It signals NIH is looking for robust testing of implementation strategies or service delivery models that can be evaluated with clinical-trial rigor, rather than purely observational studies or descriptive program reports. The emphasis is on how to implement comprehensive HIV services effectively and sustainably in SSP contexts.
Who is eligible to apply for this grant opportunity?
Eligibility is broad and includes: state, county, city or township governments; special district governments; independent school districts; public housing authorities/Indian housing authorities; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized tribal governments and other tribal organizations; nonprofits with or without 501(c)(3) status; for-profit organizations (other than small businesses) and small businesses; and other entities.
Are mission-driven and community-based institutions specifically encouraged or included?
Yes. The announcement emphasizes inclusion of organizations such as HBCUs, Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, AANAPISIs, faith-based and community-based organizations, regional organizations, and U.S. territories or possessions.
Are non-U.S. (foreign) organizations eligible to apply directly?
No. Non-domestic (non-U.S.) entities and non-domestic components of U.S. organizations are not eligible to apply.
Are foreign components allowed if a U.S. organization applies?
Yes. Foreign components, as defined by NIH policy, are allowed. This typically means a U.S. applicant may include certain foreign collaborations or activities when appropriately justified and compliant with NIH rules.
What federal agency is offering this opportunity?
The opportunity is offered under the National Institutes of Health (NIH).
How is this opportunity categorized in the listing provided?
It is listed as a discretionary grant in the education and health activity category.
What is the CFDA number associated with this opportunity?
The CFDA number provided is 93.279.
What is the closing date shown for the opportunity?
The original closing date shown is 2023-08-11.
What is the record creation date shown for the opportunity?
The record creation date shown is 2022-02-25.
Does the provided information include an award ceiling or the expected number of awards?
No. The provided announcement text does not specify an award ceiling or the expected number of awards, indicating those details were not included in the excerpt or were not set in the source listing.
Browse more opportunities from the same category: Education, Health
Next opportunity: Comprehensive Alcohol Research Centers (P60 Clinical trial Optional)
Previous opportunity: 2022 Preservation Technology and Training Grants
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DA 23 006
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DA 23 006) also looked into and applied for these:
| Funding Opportunity |
|---|
| Cancer Control Research in Persistent Poverty Areas (U54 Clinical Trial Optional) Apply for RFA CA 22 015 Funding Number: RFA CA 22 015 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Bioengineering Partnerships with Industry (U01 Clinical Trial Optional) Apply for PAR 22 123 Funding Number: PAR 22 123 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed) Apply for RFA HL 23 007 Funding Number: RFA HL 23 007 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Enhancing Social Connectedness and Ameliorating Loneliness to Prevent and Treat SUD and Support Recovery (R21 - Clinical Trial Not Allowed) Apply for RFA DA 23 009 Funding Number: RFA DA 23 009 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Enhancing Social Connectedness and Ameliorating Loneliness to Prevent and Treat SUD and Support Recovery (R34 - Clinical Trial Optional) Apply for RFA DA 23 010 Funding Number: RFA DA 23 010 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Short-Term Research Education Experiences to Attract Talented Students to Biomedical Informatics/Data Science Careers and Enhance Diversity (R25 Clinical Trial Not Allowed) Apply for RFA LM 22 001 Funding Number: RFA LM 22 001 Agency: National Institutes of Health Category: Education, Health Funding Amount: $125,000 |
| NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional) Apply for PAR 22 133 Funding Number: PAR 22 133 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Single Cell Opioid Responses in the Context of HIV (SCORCH) Program Expansion: CNS Data Generation for Chronic Opioid, Methamphetamine, Cocaine and/or Cannabinoid Exposures (U01 - Clinical Trial Not Allowed) Apply for RFA DA 23 004 Funding Number: RFA DA 23 004 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed) Apply for RFA DA 23 014 Funding Number: RFA DA 23 014 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed) Apply for RFA CA 22 017 Funding Number: RFA CA 22 017 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed) Apply for PAR 22 126 Funding Number: PAR 22 126 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Focused Technology Research and Development (R01 Clinical Trial Not Allowed) Apply for PAR 22 127 Funding Number: PAR 22 127 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) Apply for RFA CA 22 023 Funding Number: RFA CA 22 023 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) Apply for RFA CA 22 024 Funding Number: RFA CA 22 024 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) Apply for RFA CA 22 022 Funding Number: RFA CA 22 022 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional) Apply for RFA CA 22 021 Funding Number: RFA CA 22 021 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| PDX Data Commons and Coordinating Center (PDCCC) for the PDX Development and Trial Centers Research Network (PDXNet) (U24 Clinical Trial Not Allowed) Apply for RFA CA 22 013 Funding Number: RFA CA 22 013 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Patient Derived Xenograft (PDX) Development and Trial Centers (PDTCs) Network (U54 Clinical Trial Not Allowed) Apply for RFA CA 22 012 Funding Number: RFA CA 22 012 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R43/R44 - Clinical Trial Optional) Apply for RFA DA 23 021 Funding Number: RFA DA 23 021 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Enhancing HIV Reservoir Susceptibility to Elimination (R01 Clinical Trial Not Allowed) Apply for RFA AI 22 025 Funding Number: RFA AI 22 025 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 23 006", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
